Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Net Cash Flow (2022 - 2023)

Historic Net Cash Flow for Therapeutics (LENZ) over the last 2 years, with Q4 2023 value amounting to -$7.7 million.

  • Therapeutics' Net Cash Flow rose 1100.33% to -$7.7 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$9.3 million, marking a year-over-year increase of 9717.51%. This contributed to the annual value of -$14.9 million for FY2024, which is 5985.38% down from last year.
  • Per Therapeutics' latest filing, its Net Cash Flow stood at -$7.7 million for Q4 2023, which was up 1100.33% from -$31.6 million recorded in Q3 2023.
  • Therapeutics' 5-year Net Cash Flow high stood at $70.4 million for Q1 2023, and its period low was -$191.9 million during Q1 2022.